...
首页> 外文期刊>Journal of Basic and Applied Sciences >Diclofenac Sodium Inhibits Hepatic Tryptophan 2,3-Dioxygenase but Augments Brain Indoleamine 2,3-Dioxygenase Activities in Rats
【24h】

Diclofenac Sodium Inhibits Hepatic Tryptophan 2,3-Dioxygenase but Augments Brain Indoleamine 2,3-Dioxygenase Activities in Rats

机译:双氯芬酸钠抑制大鼠肝脏色氨酸2,3-双加氧酶但增强大鼠脑中吲哚胺2,3-双加氧酶的活性

获取原文
           

摘要

Tryptophan2,3-dioxygenase(TDO)existonlyinliverwhileindoleamine2,3-dioxygenase(IDO)existsubiquitouslyinthebody,thesearethemostrate-limitingenzymesofkynureninepathway(KP).Inresponsetoelevatedlevelsofcortisolandpro-inflammatorycytokines,bothenzymesshowincreaseactivityinpatientswithdepressionorAlzheimerdisease(AD).Non-steroidalanti-inflammatorydrugsmayprotectagainstbothdepressionandAD,butobservationalstudieshaveofferedcontradictoryresults.Presentstudyevaluatestheeffectsofanti-inflammatorydiclofenacsodium(DS)onrathepaticTDOandbrainIDOactivities.AdultAlbinoWistarratsweredividedintocontrolandtestgroups,eachtestgroupreceivedDS(2mg/kg)i.p.injectiondailyandwerekilledeitherafter3.5hours(acutetreatment)orafter3,5and7days(chronictreatment)whilecontrolgroupsreceivedanequalvolumeofvehicle.ResultsshowthatTDOenzymeactivitywasinhibitedandlivertryptophanconcentrationswereincreasedafter3to7daystreatmentofDS;howevernoeffectwasseenontheseparametersafter3.5hrs.BrainIDOactivitywasincreasedafterbothacuteandchronicDStreatment.ItisconcludedthatDSinhibitshepaticTDOenzymeactivityfollowingchronictreatment,whileaugmentsbrainIDOactivityfollowingbothacuteandchronicDStreatment,thismayresultinriseincerebralkynurenicacidand/orquinolinicacidconcentrations.ThereforethereisaneedthateffectsofDSonkynureninepathwayshouldbefurtherinvestigatedtoruleouttheprotectiveeffectofDSininflammation-induceddepressionandAlzheimerdisease.
机译:Tryptophan2,3双加氧酶(TDO)existonlyinliverwhileindoleamine2,3双加氧酶(IDO)existsubiquitouslyinthebody,thesearethemostrate-limitingenzymesofkynureninepathway(KP).Inresponsetoelevatedlevelsofcortisolandpro-inflammatorycytokines,bothenzymesshowincreaseactivityinpatientswithdepressionorAlzheimerdisease(AD)。非甾体inflammatorydrugsmayprotectagainstbothdepressionandAD,butobservationalstudieshaveofferedcontradictoryresults.Presentstudyevaluatestheeffectsofanti-inflammatorydiclofenacsodium(DS)onrathepaticTDOandbrainIDOactivities。 AdultAlbinoWistarratsweredividedintocontrolandtestgroups,eachtestgroupreceivedDS(2毫克/千克)ipinjectiondailyandwerekilledeitherafter3.5hours(acutetreatment)orafter3,5and7days(chronictreatment)whilecontrolgroupsreceivedanequalvolumeofvehicle.ResultsshowthatTDOenzymeactivitywasinhibitedandlivertryptophanconcentrationswereincreasedafter3to7daystreatmentofDS; howevernoeffectwasseenontheseparametersafter3.5hrs.BrainIDOactivitywasincreasedafterbothacuteandchr离子性DS处理。在连续和慢性DS处理后,发现DS抑制了肝的TDO酶活性,而在急性和慢性DS处理之后却增强了脑IDO活性,这可能导致脑中的尿酸和/或喹啉酸浓度升高,从而降低了对DS的保护性,从而降低了对DS的保护性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号